Bret E. Megargel

IpiNovyx Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat autoimmune and inflammatory diseases through selective inhibition of the immunoproteasome. The company is based in West Nyack, NY. The company's platform technology enables highly selective, reversible, and non-toxic inhibition of various immune cell types, with applications across a range of indications with underlying immunopathology. Orange Grove Bio (OGB) is an emerging, preclinical, capital allocation, and asset development biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company was founded by Jim Graham, and the CEO is Marc Appel.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN.

Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million.

Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA.

Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation.

Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom.

PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ.

Part of Exelixis, Inc., Metaxen LLC is an American company that provides compound screening assays and compound optimization services. The company was founded by Lutz B. Giebel, Michael Jay Ross.

Good Start Genetics, Inc. operates as a molecular diagnostics firm. It offers pre-pregnancy diagnostic test services to screen a panel of genetic disorders. The firm also provides clinical laboratory and genetic counseling support services. The company was founded by Eric Boutin, Paris Wallace, and Gregory J. Porreca in December 2007 and is headquartered in Cambridge, MA.

AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA.

General Atomics develops and manufactures high-technology products for commercial, and government applications. It offers nuclear fuel cycle, electromagnetic systems, remotely operated surveillance aircraft, airborne sensors, and high-power lasers. The company was founded in 1955 and is headquartered in San Diego, CA.

Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI.

Incline Therapeutics, Inc. develops pharmaceutical products. The firm operates as hospital-focused specialty pharmaceutical company focused on the development of IONSYS (fentanyl iontophoretic transdermal system). The company was founded in 2009 and is headquartered in Seatle, WA.

Part of Beckley Psytech Ltd., Eleusis Holdings Ltd. is a life science company based in London, UK. The British company is leading translational research in bold new directions and developing a broad and differentiated portfolio of drug candidates to address unmet needs within and beyond psychiatry. Eleusis is dedicated to transforming psychedelics into medicines, empowering patients, and facilitating access to care. The company was founded in 2017. The CEO is Shlomi Raz. Eleusis Holdings was acquired by Beckley Psytech Ltd.

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Nexcida Therapeutics, Inc. operates in the field of infectious disease therapeutics. The company was founded by Yigong Ge and is headquartered in Menlo Park, CA.

Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA.

Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA.

Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA.

Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan.

Kaiser Associates, Inc. provides boutique strategy consulting services. The private company is based in Washington. Loren Eric Kaiser has been the CEO of the American company since 1999.

MiraMedica, Inc. supplies, equipment and diagnostic imaging devices. It also supplies digital imaging devices. The company is located in Los Gatos, CA.